The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
History of the design of captopril and related inhibitors of angiotensin converting enzyme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ondetti, M. A., Rubin, B., & Cushman, D. W. (1977) · Science · doi:10.1126/science.191908 · Cited by 1,856
Self-citationCushman, D. W., Cheung, H. S., Sabo, E. F., & Ondetti, M. A. (1977) · Biochemistry · doi:10.1021/bi00644a014 · Cited by 892
Self-citationOndetti, M. A., Williams, N. J., Sabo, E., Pluscec, J., Weaver, E. R., & Kocy, O. (1971) · Biochemistry · doi:10.1021/bi00798a004 · Cited by 521
Self-citationA BRADYKININ‐POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARACA
FERREIRA, S. H. (1965) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1965.tb02091.x · Cited by 509
Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom
J.P. (1971) · Toxicon · doi:10.1016/0041-0101(71)90098-5 · Cited by 480
Gavras, H., Brunner, H. R., Laragh, J. H., Sealey, J. E., Gavras, I., & Vukovich, R. A. (1974) · New England Journal of Medicine · doi:10.1056/nejm197410172911603 · Cited by 353
Cheung, H. S., & Cushman, D. W. (1973) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(73)90352-5 · Cited by 271
Self-citationConversion of Angiotensin I to Angiotensin II by Cell-free Extracts of Dog Lung
BAKHLE, Y. S. (1968) · Nature · doi:10.1038/220919a0 · Cited by 258
Binding of the by-product analog benzylsuccinic acid by carboxypeptidase A
Byers, L. D., & Wolfenden, R. (1973) · Biochemistry · doi:10.1021/bi00735a008 · Cited by 195
Peart, W. S. (1976) · doi:10.1007/978-1-349-02718-7_10 · Cited by 137
Cited by
The biochemistry and medical significance of the flavonoids
Havsteen, B. H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00298-x · Cited by 2,672
Venoms as a platform for human drugs: translating toxins into therapeutics
King, G. F. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.621940 · Cited by 516
Angiotensin-converting enzyme inhibitor fetopathy.
Pryde, P. G., Sedman, A. B., Nugent, C. E., & Barr, M. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v391575 · Cited by 332
Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
Pinter, M., & Jain, R. K. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan5616 · Cited by 332
eToxPred: a machine learning-based approach to estimate the toxicity of drug candidates
Pu, L., Naderi, M., Liu, T., Wu, H.-C., Mukhopadhyay, S., & Brylinski, M. (2019) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-018-0282-6 · Cited by 212
“Captopril, an angiotensin-converting enzyme inhibitor, was one of the first success stories of LBDD, which was considered a revo-lutionary concept in 1970s compared to conventional methods [11].”
Result
Metadata
- Authors
- Cushman, D. W., & Ondetti, M. A.
- Venue
- Hypertension
- Published
- 1991-04
- Volume
- 17
- Issue
- 4
- Pages
- 589-592
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2024825709
- Cited by
- 270
- References
- 14
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: History of the design of captopril and related inhibitors of angiotensin converting enzyme. https://app.cochat.ai/papers/10.1161/01.hyp.17.4.589
- The paper
- Cushman, D. W., & Ondetti, M. A. (1991). History of the design of captopril and related inhibitors of angiotensin converting enzyme. Hypertension. https://doi.org/10.1161/01.hyp.17.4.589
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
